SPL 3.13% 9.9¢ starpharma holdings limited

Is a Peer Review required for Viraleze covid viral load claim?, page-16

  1. 9,398 Posts.
    lightbulb Created with Sketch. 878
    Beware of the weasel words of potentially be of significant benefit for people over 45? How weak were the stats that even in a age subset it is still a wishy washy statement IMO

    It doesn't even say they spray :will should or would - it say "Could" have clinical benefit in over 45 group?

    I hope they can do something with data that is positive so it wasn't just $ pissed against the wall but I'll wait and see as their lack of communication is my biggest red flag and so crazy as I don't believe commenting would disadvantage SPL. It would advantage SPL and markets full understanding of trial results .
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.